1. Crocq MA. A history of anxiety: from Hippocrates to DSM. Dialogues Clin Neurosci. 2015 Sep;17(3): 319-25. [DOI:10.31887/DCNS.2015.17.3/macrocq]

2. Tovote P, Fadok JP, Lüthi A. Neuronal circuits for fear and anxiety. Nat Rev Neurosci. 2015 Jun;16(6):317-31. [DOI:10.1038/nrn3945]

3. Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014 Sep;23(133):345-9. [DOI:10.1183/09059180.00007813]

4. Tully, P.J., Harrison, N.J., Cheung, P. Anxiety and Cardiovascular Disease Risk: a Review. Curr Cardiol Rep 18, 120 (2016). [DOI:10.1007/s11886-016-0800-3]

5. 5 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. [DOI:10.1016/S0140-6736(20)30183-5]

6. Surveillances V. The epidemiological characteristics of an out break of 2019 novel Coronavirus Diseases (COVID-19)-China.China CDC Weekly. 2020; 2(8):113-22. [DOI:10.46234/ccdcw2020.032]

7. Abdolahi S, Gorji A. COVID-19: The potential role of nutritional deficiencies, global climatic changes, and immune system dysfunction. Iranian Journal of War and Public Health. 2020 Nov 10;12(4): 249-258. [DOI:10.52547/ijwph.12.4.249]

8. Chan JF-W, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. Afamilial cluster of pneumonia associated with the 2019 novel Coronavirus indicating person-to-person transmission: A study of a family cluster. The Lancet. 2020; 395(10223): 514-23. [DOI:10.1016/S0140-6736(20)30154-9]

9. Dong X, Cao Y-Y, Lu X-X. Eleven faces of coronavirus disease 2019. Allergy. 2020; 75: 1699- 709. [DOI:10.1111/all.14289]

10. Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron L, Pagliaro P, et al. COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. JCR 2020: 1-29. [DOI:10.1007/s11357-020-00198-w]

11. Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association be-tween COVID-19 mortality and health-care resource availability. The Lancet Global Health. 2020; 8(4):e480. [DOI:10.1016/S2214-109X(20)30068-1]

12. Ou M, Zhu J, Ji P, Li H, Zhong Z, Li B, et al. Risk factors of severe cases with COVID-19: A meta-analysis. Epidemiology & Infection. 2020; 148: e175. [DOI:10.1017/S095026882000179X]

13. Rahman A, Sathi NJ. Risk factors of the severity of COVID‐19:A meta‐analysis. International Journal of Clinical Practice. 2020; e13916. [DOI:10.1101/2020.04.30.20086744]

14. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323(20): 2052-9. [DOI:10.1001/jama.2020.6775]

15. Fortin M, Lapointe L, Hudon C, Vanasse A. Multimorbidity is common to family practice: Is it commonly researched? Canadian Family Physician. 2005; 51(2): 244-5.

16. Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wit- tenberg E, et al. Depression, self-care, and medication adherence in type 2 diabetes: Relationships across the full range of symptom severity. Diabetes Care. 2007; 30(9): 2222-7. [DOI:10.2337/dc07-0158]

17. Salari-Moghaddam S, Ranjbar A, Fathi-Ashtiani A. Validity and Reliability measurement of the Persian version of anxiety Control Questionnaire. Journal of Clinical Psychology, 2018; 9(4): 33-43.